Parvovax

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Porcine parvovirus

Available from:

Ceva Animal Health Ltd

ATC code:

QI09AA02

INN (International Name):

Porcine parvovirus

Pharmaceutical form:

Emulsion for injection

Prescription type:

POM-V - Prescription Only Medicine – Veterinarian

Therapeutic group:

Pigs

Therapeutic area:

Inactivated Viral Vaccine

Authorization status:

Authorized

Authorization date:

2005-10-17

Summary of Product characteristics

Revised: October 2022
AN: 01675/2022
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISITICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
PARVOVAX
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each 2-ml dose of vaccine contains:
Inactivated porcine parvovirus, minimum …………… 2.0 HAI.U
Thiomersal,maximum…………………………………… 0.2 mg
Oily adjuvant which includes light paraffin oil…
449.6 to 488.2 mg
Benzyl alcohol………………………………………
10.56mg
1 HAI.U: q.s. to obtain HAI antibody titres of 1 log10 in guinea-pigs
after
administration of the vaccine.
For full list of excipients, see section 6.1
3.
PHARMACEUTICAL FORM
Emulsion for injection.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Breeder pigs.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For active immunisation of breeder pigs (gilts, sows, boars) against
porcine parvovirus, to reduce the number of stillbirths and mummified
foetuses in vaccinates. The onset of immunity is obtained from 2 to 3
weeks after the primary vaccination. This immunity persists for up to
one
year.
Revised: October 2022
AN: 01675/2022
Page 2 of 6
4.3
CONTRA-INDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Vaccinate only healthy animals. Vaccinate sows during lactation.
4.5
SPECIAL PRECAUTIONS FOR USE
(I) SPECIAL PRECAUTIONS FOR USE IN ANIMALS
None.
(II) SPECIAL PRECAUTIONS TO BE TAKEN BY THE PERSON ADMINISTERING THE
VETERINARY MEDICINAL PRODUCT TO THE ANIMALS
Apply usual aseptic procedures.
To the user:
This product contains mineral oil. Accidental injection/self injection
may
result in severe pain and swelling, particularly if injected into a
joint or
finger, and in rare cases could result in the loss of the affected
finger if
prompt medical attention is not given.
If you are accidentally injected with this product, seek prompt
medical
advice even if only a very small amount is injected and take the
package
leaflet with you.
If pain persists for more than 12 hours after medical examination,
seek
medical advice again.
To the